1. Home
  2. LSCC vs VTRS Comparison

LSCC vs VTRS Comparison

Compare LSCC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • VTRS
  • Stock Information
  • Founded
  • LSCC 1983
  • VTRS 1961
  • Country
  • LSCC United States
  • VTRS United States
  • Employees
  • LSCC N/A
  • VTRS N/A
  • Industry
  • LSCC Semiconductors
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • LSCC Technology
  • VTRS Health Care
  • Exchange
  • LSCC Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • LSCC 9.8B
  • VTRS 11.1B
  • IPO Year
  • LSCC 1989
  • VTRS N/A
  • Fundamental
  • Price
  • LSCC $73.70
  • VTRS $9.96
  • Analyst Decision
  • LSCC Strong Buy
  • VTRS Hold
  • Analyst Count
  • LSCC 11
  • VTRS 5
  • Target Price
  • LSCC $68.73
  • VTRS $10.40
  • AVG Volume (30 Days)
  • LSCC 2.6M
  • VTRS 11.4M
  • Earning Date
  • LSCC 11-03-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • LSCC N/A
  • VTRS 4.81%
  • EPS Growth
  • LSCC N/A
  • VTRS N/A
  • EPS
  • LSCC 0.23
  • VTRS N/A
  • Revenue
  • LSCC $488,631,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • LSCC $3.96
  • VTRS N/A
  • Revenue Next Year
  • LSCC $19.53
  • VTRS $1.69
  • P/E Ratio
  • LSCC $320.31
  • VTRS N/A
  • Revenue Growth
  • LSCC N/A
  • VTRS N/A
  • 52 Week Low
  • LSCC $34.69
  • VTRS $6.85
  • 52 Week High
  • LSCC $76.62
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 59.72
  • VTRS 55.66
  • Support Level
  • LSCC $70.97
  • VTRS $10.06
  • Resistance Level
  • LSCC $75.22
  • VTRS $10.26
  • Average True Range (ATR)
  • LSCC 2.26
  • VTRS 0.21
  • MACD
  • LSCC -0.40
  • VTRS 0.05
  • Stochastic Oscillator
  • LSCC 42.71
  • VTRS 75.07

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: